In vitro activity of fusidic acid and mupirocin against coagulase-positive staphylococci from pets | Zendy

Anette Loeffler | Zendy; Stephen Baines | Zendy; Mark A. Toleman | Zendy; D. Felmingham | Zendy; S. K. Milsom | Zendy; E. A. Edwards | Zendy; D. H. Lloyd | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

In vitro activity of fusidic acid and mupirocin against coagulase-positive staphylococci from pets

Author(s) -

Anette Loeffler,

Stephen Baines,

Mark A. Toleman,

D. Felmingham,

S. K. Milsom,

E. A. Edwards,

D. H. Lloyd

Publication year - 2008

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkn398

Subject(s) - fusidic acid , mupirocin , staphylococcus pseudintermedius , microbiology and biotechnology , antibiotics , staphylococcus aureus , staphylococcal infections , agar dilution , methicillin resistant staphylococcus aureus , biology , medicine , staphylococcus , minimum inhibitory concentration , bacteria , genetics

Methicillin-resistant Staphylococcus aureus (MRSA) and multiresistant Staphylococcus pseudintermedius (MRSP) have emerged as important pathogens in animal infections. Associated therapeutic problems and the zoonotic potential of staphylococci have renewed interest in topical antibiotics for treatment and carrier decolonization. Fusidic acid and mupirocin are used topically in humans and animals but resistant strains isolated from people are increasing. This study investigates the in vitro activity of fusidic acid and mupirocin against coagulase-positive staphylococci from pets.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research